The Youngest APS-2 Patient on Record: A Toddler's Case Illuminates How Early Autoimmunity Can Cluster
Autoimmune Polyendocrine Syndrome Type 2, or APS-2, is a condition defined by the coexistence of at least two autoimmune endocrine disorders in the same person. The most common pairings include type 1 diabetes, autoimmune thyroid disease (such as Hashimoto's thyroiditis or Graves' disease), and Addison's disease (adrenal insufficiency). Unlike APS-1, which is caused by a single faulty gene, APS-2 arises from a more complex interplay of multiple genetic risk factors, particularly variants in the HLA region of the genome that shape how the immune system identifies friend from foe. APS-2 tends to run in families and typically appears in early adulthood, though it can emerge at any age.
That last point is made vivid by a remarkable case report published in BMC Pediatrics in May 2025 by researchers at Lanzhou University in China. They describe a 3-year-old girl who became the youngest patient with APS-2 ever documented in the medical literature. The case also represents the shortest interval ever recorded between the onset of separate autoimmune conditions within a single patient, meaning the different components of her illness emerged in rapid succession rather than over years or decades.
The child first came to medical attention with signs of hyperthyroidism and exophthalmos, the bulging of the eyes that often accompanies Graves' disease. Graves' disease is an autoimmune condition in which antibodies mistakenly stimulate the thyroid gland, causing it to overproduce thyroid hormone. This leads to symptoms like rapid heartbeat, weight loss, anxiety, and heat intolerance. In this child's case, the prominent eye signs raised the alarm that brought her to doctors. Shortly after, she was also diagnosed with type 1 diabetes mellitus, a condition in which the immune system destroys the insulin-producing beta cells in the pancreas. Then came a third diagnosis: myasthenia gravis, a neuromuscular disorder in which immune-mediated attack on acetylcholine receptors at nerve-muscle junctions causes fluctuating muscle weakness and fatigue.
The combination of autoimmune thyroid disease, type 1 diabetes, and myasthenia gravis in a toddler is extraordinarily rare. The authors conducted a retrospective literature review to better understand the immune mechanisms that could produce such an early and aggressive autoimmune cluster. HLA susceptibility alleles, shared between different autoimmune conditions, appear to play a central role. When a child carries multiple susceptibility variants, the immune system may be prone to misidentifying several different tissues as threats, setting multiple autoimmune processes in motion nearly simultaneously.
From a clinical standpoint, this case reinforces a principle that is increasingly important in pediatric medicine: when one autoimmune condition is diagnosed in a child, clinicians should actively screen for others. Autoimmune disorders rarely travel alone, and catching companion conditions early, before symptoms become severe, allows for better-coordinated treatment and can prevent serious complications. The authors emphasize that this case should help pediatricians and endocrinologists recognize that APS-2 is not exclusively an adult disease, and that its earliest presentations may look different from what is described in adult-focused clinical guidelines. Early recognition and targeted monitoring remain the best tools available to families and care teams navigating this complex condition.